Anavex Life Sciences Corp. ( AVXL) - Key Metrics
AVXL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q3 | $0 | -$0.03 | -$0.15 | -$0.15 |
| 2026Q2 | $0 | -$0.06 | -$0.05 | -$0.05 |
| 2026Q1 | $0 | -$0.06 | -$0.08 | -$0.08 |
| 2025Q4 | $0 | -$0.11 | -$0.10 | -$0.10 |
| 2025Q3 | $0 | -$0.16 | -$0.15 | -$0.15 |
AVXL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q3 | 0% | -21.58 |
| 2026Q2 | 0% | -13.32 |
| 2026Q1 | 0% | -13.95 |
| 2025Q4 | 0% | -20.23 |
| 2025Q3 | 0% | -14.41 |
AVXL
Price: $1.31
52 week price:
Earnings Per Share: -0.13 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.1 million
Ebitda: -4.1 millionMarket Capitalization: 168.7 million